“Comparative clinical trials of the drugs“ Hydroxychloroquine ”,“ Mefloquine ”and the Russian drug“ Kalidavir ”, which will be used according to new medical indications for the treatment of patients with a new coronavirus infection SARS-CoV-2, have begun,” the press service said. leads RIA Novosti.

The studies will be carried out with the written consent of patients with coronavirus at the Burnazyan State Medical Center.

Previously, FMBA presented a treatment regimen for severe coronavirus pneumonia based on the use of the drug “Dalargin”, which is used for pulmonary edema.